Incorporating Community Engagement Strategies into U.S. Biomedical Research Regulation
 

Based on a 2011 search of the National Clinical Trials Register (ClinicalTrials.Gov), I discussed the characteristics of race-based biomedical research currently enrolling participants in the U.S. and overseas. Using this information as an evidence base, I set out a possible model for incorporating community engagement strategies in the regulation of biomedical research in the U.S.: in particular, through the use of race impact assessments. My hope was to provide a springboard for discussion about linking community engagement goals - here, promoting greater thoughtfulness in study design and execution, and allowing potentially affected group members a voice in decision-making - with regulatory targets and strategies.